130
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Machine Learning-Based CEMRI Radiomics Integrating LI-RADS Features Achieves Optimal Evaluation of Hepatocellular Carcinoma Differentiation

, , , &
Pages 2103-2115 | Received 06 Sep 2023, Accepted 22 Nov 2023, Published online: 29 Nov 2023

References

  • Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
  • Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet Lond Engl. 2018;391(10127):1301–1314. doi:10.1016/S0140-6736(18)30010-2
  • Shinkawa H, Tanaka S, Kabata D, et al. The prognostic impact of tumor differentiation on recurrence and survival after resection of hepatocellular carcinoma is dependent on tumor size. Liver Cancer. 2021;10(5):461–472. doi:10.1159/000517992
  • Zhou L, Rui JA, Zhou WX, et al. Edmondson-Steiner grade: a crucial predictor of recurrence and survival in hepatocellular carcinoma without microvascular invasio. Pathol Res Pract. 2017;213(7):824–830. doi:10.1016/j.prp.2017.03.002
  • Kleiner DE. Hepatocellular carcinoma: liver biopsy in the balance. Hepatology. 2018;68(1):13–15. doi:10.1002/hep.29831
  • Gong XQ, Tao YY, Wu Y, et al. Progress of MRI radiomics in hepatocellular carcinoma. Front Oncol. 2021;11:698373. doi:10.3389/fonc.2021.698373
  • Vietti Violi N, Lewis S, Liao J, et al. Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screening. Eur Radiol. 2020;30(11):6003–6013. doi:10.1007/s00330-020-07014-1
  • Kong C, Zhao Z, Chen W, et al. Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE. Eur Radiol. 2021;31(10):7500–7511. doi:10.1007/s00330-021-07910-0
  • Swanson K, Wu E, Zhang A, et al. From patterns to patients: advances in clinical machine learning for cancer diagnosis, prognosis, and treatment. Cell. 2023;186(8):1772–1791. doi:10.1016/j.cell.2023.01.035
  • Moura Cunha G, Chernyak V, Fowler KJ, et al. Up-to-date role of CT/MRI LI-RADS in hepatocellular carcinoma. J Hepatocell Carcinoma. 2021;8:513–527. doi:10.2147/JHC.S268288
  • Loy LM, Low HM, Choi JY, et al. Variant hepatocellular carcinoma subtypes according to the 2019 WHO classification: an imaging-focused review. Am J Roentgenol. 2022;219(2):212–223. doi:10.2214/AJR.21.26982
  • Li H, Wu Z, Chen J, et al. External radiotherapy combined with sorafenib has better efficiency in unresectable hepatocellular carcinoma: a systematic review and meta-analysis. Clin Exp Med. 2023;23(5):1537–1549. doi:10.1007/s10238-022-00972-4
  • Su K, Shen Q, Tong J, et al. Construction and validation of a nomogram for HBV-related hepatocellular carcinoma: a large, multicenter study. Ann Hepatol. 2023;28(4):101109. doi:10.1016/j.aohep.2023.101109
  • Su K, Huang W, Xu K, et al. Evaluation of lactate dehydrogenase and alkaline phosphatase as predictive biomarkers in the prognosis of hepatocellular carcinoma and development of a new nomogram. J Hepatocell Carcinoma. 2023;10:69–79. doi:10.2147/JHC.S398632
  • Li H, Su K, Jiang Y, et al. Construction and validation of TACE therapeutic efficacy by ALR score and nomogram: a large, multicenter study. J Hepatocell Carcinoma. 2023;10:1009–1017. doi:10.2147/JHC.S414926
  • Castaldo A, De Lucia DR, Pontillo G, et al. State of the art in artificial intelligence and radiomics in hepatocellular carcinoma. Diagnostics. 2021;11(7):1194. doi:10.3390/diagnostics11071194
  • Han YE, Cho Y, Kim MJ, et al. Hepatocellular carcinoma pathologic grade prediction using radiomics and machine learning models of gadoxetic acid-enhanced MRI: a two-center study. Abdom Radiol. 2022;48(1):244–256. doi:10.1007/s00261-022-03679-y
  • Ameli S, Venkatesh BA, Shaghaghi M, et al. Role of MRI-derived radiomics features in determining degree of tumor differentiation of hepatocellular carcinoma. Diagnostics. 2022;12(10):2386. doi:10.3390/diagnostics12102386
  • Mao Y, Wang J, Zhu Y, et al. Gd-EOB-DTPA-enhanced MRI radiomic features for predicting histological grade of hepatocellular carcinoma. Hepatobiliary Surg Nutr. 2022;11(1):13–24. doi:10.21037/hbsn-19-870
  • Brancato V, Garbino N, Salvatore M, et al. MRI-based radiomic features help identify lesions and predict histopathological grade of hepatocellular carcinoma. Diagnostics. 2022;12(5):1085. doi:10.3390/diagnostics12051085
  • Yang X, Yuan C, Zhang Y, et al. Magnetic resonance radiomics signatures for predicting poorly differentiated hepatocellular carcinoma: a SQUIRE-compliant study. Medicine. 2021;100:19..
  • Usta S, Kayaalp C. Tumor diameter for hepatocellular carcinoma: why should size matter? J Gastrointest Cancer. 2020;51(4):1114–1117. doi:10.1007/s12029-020-00483-z
  • Huang K, Dong Z, Cai H, et al. Imaging biomarkers for well and moderate hepatocellular carcinoma: preoperative magnetic resonance image and histopathological correlation. BMC Cancer. 2019;19(1):364. doi:10.1186/s12885-019-5574-8
  • Kovac JD, Ivanovic A, Milovanovic T, et al. An overview of hepatocellular carcinoma with atypical enhancement pattern: spectrum of magnetic resonance imaging findings with pathologic correlation. Radiol Oncol. 2021;55(2):130–143. doi:10.2478/raon-2021-0004
  • Liu HF, Zhang YZZ, Wang Q, et al. A nomogram model integrating LI-RADS features and radiomics based on contrast-enhanced magnetic resonance imaging for predicting microvascular invasion in hepatocellular carcinoma falling the Milan criteria. Transl Oncol. 2023;27:101597. doi:10.1016/j.tranon.2022.101597
  • Xu L, Li L, Wang P, et al. Novel prognostic nomograms for hepatocellular carcinoma patients with microvascular invasion: experience from a single center. Gut Liver. 2019;13(6):669–682. doi:10.5009/gnl18489